Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure
Fazia Mir, Alp S Kahveci, Jamal A Ibdah, Veysel Tahan Division of Gastroenterology and Hepatology, University of Missouri, Columbia, MO, USA Abstract: Hepatitis C virus (HCV) is a global pandemic, with nearly 200 million infected patients worldwide. HCV is the most common blood-borne infection in...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2017-02-01
|
| Serija: | Drug Design, Development and Therapy |
| Teme: | |
| Online dostop: | https://www.dovepress.com/sofosbuvirvelpatasvir-regimen-promises-an-effective-pan-genotypic-hepa-peer-reviewed-article-DDDT |
| Oznake: |
Brez oznak, prvi označite!
|